Citi Maintains XP Inc(XP.US) With Buy Rating
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Maintains Target Price $24
XP Inc: Hold Rating Maintained Amid Stable Valuation and Modest Earnings Adjustment
BofA Securities Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $25
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Maintains Target Price $24
BofA Securities Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $25
Citi Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $27
Strong Performance and Promising Outlook Justify Buy Rating for XP Inc.
XP Analyst Ratings
Goldman Sachs Maintains Neutral on XP, Lowers Price Target to $19
XP Analyst Ratings
UBS Downgrades XP to Neutral From Buy, Cuts Price Target to $21 From $30
Bradesco BBI Downgrades XP to Neutral From Outperform, Cuts Price Target to $19 From $31
XP Analyst Ratings
B of A Securities Maintains Buy on XP, Lowers Price Target to $25
XP Analyst Ratings
Citigroup Maintains Buy on XP, Lowers Price Target to $27
Goldman Sachs: Lowered the XP (XP.US) rating from buy to neutral, and adjusted the target price from $30.00 to $23.00.
XP Analyst Ratings
Goldman Sachs Downgrades XP to Neutral, Lowers Price Target to $23